Publications by authors named "M Jullien"

Claim this Profile
T
Thiotepa-busulfan-fludarabine compared to clofarabine-based conditioning for haploidentical transplant with posttransplant cyclophosphamide in patients with myeloid malignancies: a retrospective study from the SFGM-TC.
Maxime Jullien, Eolia Brissot, Etienne Daguindau, Michael Loschi, Ali Bazarbachi

Bone Marrow Transplant· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leveraging the heterogeneity of the NK cell repertoire for the development of immunotherapies for acute leukemia.
Enora Ferron, Maxime Jullien, Katia Gagne, Christelle Retière

J Transl Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional recovery of NK cells after T-cell replete haploidentical HSCT: delayed licensing and poor anti-AML activity.
Maxime Jullien, Enora Ferron, Catherine Willem, Gaelle David, Nolwenn Legrand

Blood Adv· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective right heart valve remodelling in a mouse model of carcinoid disease revealed by high-resolution episcopic microscopy.
Gaspard Suc, Mustafa Habib, Sofiane Mohammed, Gregory Franck, Samuel Sitbon, Marine Jullien

Sci Rep· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[OverView of infectious and non-infectious diseases in French Polynesia in 2025].
Erwan Oehler, Rémi Mayan, Stéphane Lastère, Jean-Marc Ségalin, Bertrand Remaudière, Marine Jullien

Med Trop Sante Int· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis